Listeria-based cancer vaccines that segregate immunogenicity from toxicity
DG Brockstedt, MA Giedlin, ML Leong… - Proceedings of the …, 2004 - National Acad Sciences
The facultative intracellular bacterium Listeria monocytogenes is being developed as a
cancer vaccine platform because of its ability to induce potent innate and adaptive immunity …
cancer vaccine platform because of its ability to induce potent innate and adaptive immunity …
[HTML][HTML] Listeria-based cancer vaccines that segregate immunogenicity from toxicity
DG Brockstedt, MA Giedlin, ML Leong… - Proceedings of the …, 2004 - ncbi.nlm.nih.gov
The facultative intracellular bacterium Listeria monocytogenes is being developed as a
cancer vaccine platform because of its ability to induce potent innate and adaptive immunity …
cancer vaccine platform because of its ability to induce potent innate and adaptive immunity …
Listeria-Based Cancer Vaccines That Segregate Immunogenicity from Toxicity
DG Brockstedt, MA Giedlin, ML Leong, KS Bahjat… - Proceedings of the …, 2004 - JSTOR
The facultative intracellular bacterium Listeria monocytogenes is being developed as a
cancer vaccine platform because of its ability to induce potent innate and adaptive immunity …
cancer vaccine platform because of its ability to induce potent innate and adaptive immunity …
Listeria-based cancer vaccines that segregate immunogenicity from toxicity
DG Brockstedt, MA Giedlin, ML Leong… - Proceedings of the …, 2004 - cir.nii.ac.jp
抄録< jats: p> The facultative intracellular bacterium< jats: italic> Listeria
monocytogenes</jats: italic> is being developed as a cancer vaccine platform because of its …
monocytogenes</jats: italic> is being developed as a cancer vaccine platform because of its …
Listeria-based cancer vaccines that segregate immunogenicity from toxicity.
DG Brockstedt, MA Giedlin, ML Leong… - Proceedings of the …, 2004 - europepmc.org
The facultative intracellular bacterium Listeria monocytogenes is being developed as a
cancer vaccine platform because of its ability to induce potent innate and adaptive immunity …
cancer vaccine platform because of its ability to induce potent innate and adaptive immunity …
[PDF][PDF] Listeria-based cancer vaccines that segregate immunogenicity from toxicity
DG Brockstedt, MA Giedlin, ML Leong, KS Bahjat… - PNAS, 2004 - researchgate.net
Materials and Methods Bacterial Host Strains and Recombinant Vectors. All Listeria strains
used in this study were derived from the L. monocytogenes wild-type strain 10403S …
used in this study were derived from the L. monocytogenes wild-type strain 10403S …
Listeria-based cancer vaccines that segregate immunogenicity from toxicity
DG Brockstedt, MA Giedlin… - Proceedings of the …, 2004 - pubmed.ncbi.nlm.nih.gov
The facultative intracellular bacterium Listeria monocytogenes is being developed as a
cancer vaccine platform because of its ability to induce potent innate and adaptive immunity …
cancer vaccine platform because of its ability to induce potent innate and adaptive immunity …
Listeria-based cancer vaccines that segregate immunogenicity from toxicity
DG Brockstedt, MA Giedlin, ML Leong… - Proceedings of the …, 2004 - ui.adsabs.harvard.edu
The facultative intracellular bacterium Listeria monocytogenes is being developed as a
cancer vaccine platform because of its ability to induce potent innate and adaptive immunity …
cancer vaccine platform because of its ability to induce potent innate and adaptive immunity …
[引用][C] Listeria-based cancer vaccines that segregate immunogenicity from toxicity
DG BROCKSTEDT - PNAS, 2004 - cir.nii.ac.jp
Listeria-based cancer vaccines that segregate immunogenicity from toxicity.
DG Brockstedt, MA Giedlin, ML Leong… - Proceedings of the …, 2004 - europepmc.org
The facultative intracellular bacterium Listeria monocytogenes is being developed as a
cancer vaccine platform because of its ability to induce potent innate and adaptive immunity …
cancer vaccine platform because of its ability to induce potent innate and adaptive immunity …